Thoracic Research and Practice
Original Article

Diagnostic Value of EBUS in Mediastinal and Hilar Lymph Nodes

1.

Yedikule Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, İstanbul, Türkiye

2.

Yedikule Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, İstanbul, Türkiye

3.

Yedikule Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, İstanbul, Turkey

4.

Yedikule Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, İstanbul, Tü

5.

Yedikule Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Cerrahisi Kliniği, İstanbul, Turkey

Thorac Res Pract 2009; 10: 162-165
Read: 1557 Downloads: 770 Published: 18 July 2019

Abstract

Objective: One of the indications for endobronchial ultrasound (EBUS) is the diagnosis of mediastinal and/or hilar lymphadenopathy. The aim of this study is to report the place of EBUS probe using a single- channel bronchoscope that allows TBNA after localisation of lymph nodes under ultrasound in the diagnosis of mediastinal and hiler lymph nodes.

 

Material and Method: Retrospectively, 45 patients were enrolled with a proven lymph node on CT and an indication for TBNA for diagnosis. Lymph nodes were verified under local anesthesia by EBUS and sampled using a Wang 22 gauge cytology needle. The EU-M30s model EBUS and UM-BS 20-26 R Olympus ultrasonic probe was used. Procedures were applied through Pentax EB 1970 model bronchoscope.

 

Results: TBNA procedures were performed using a flexible bronchoscope and a 22-gauge Wang needle in 45 consecutive patients (23 women (51.1%); mean age, 47±15 years [+/- SD] (17-74)) who had mediastinal or hilar adenopathy identified on chest CT The average number of needle passes was 5.0±1.8 (2-9) per patient. A total of 85 lymph nodes were sampled. Adequate material was found in all of the patients (100%). In 36 (80.0%) of the cases the adequate material was diagnostic. The diagnostic value of EBUS TBNA was 82.4% in sarcoidosis, 60% in tuberculosis and 100% in small cell lung carcinoma and nonsmall cell lung carcinoma.

 

Conclusion: EBUS guided TBNA of mediastinal and hilar lymph nodes is a safe approach which increases the percentage of adequate material and diagnostic yield.

Files
EISSN 2979-9139